Thursday, May 22, 2025
  • Login
Euro Times
No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
Euro Times
No Result
View All Result

Torrent Pharma – Curatio Acquisition To Strengthen Branded Portfolio: ICICI Direct

by ICICI Direct
September 28, 2022
in Business
Reading Time: 2 mins read
A A
0
Home Business
Share on FacebookShare on Twitter


BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. 

Torrent Pharmaceuticals Ltd. is set to acquire 100% of Curatio Healthcare PVt. Ltd. for Rs 2000 crore. The consideration includes Rs 115 crore of cash and cash equivalents in the acquired business indicating an enterprise value of Rs 1,885 crore.

Curatio has a strong presence in the cosmetic dermatology segment with a portfolio of over 50 brands, marketed in India. Top 10 brands of Curatio account for ~75% of total revenue.

Curatio’s portfolio consists of leading brands such as Tedibar, Atogla, Spoo, B4 Nappi, and Permite, which are ranked among top five brands in their covered market

With this deal, Torrent Pharma will enter the league of top 10 players in the dermatology segment and will be the leader in the cosmetic dermatology space.

Curatio reported revenues of Rs 224 crore in FY22 and is expected to post Rs 275 crore revenue in FY23, thus valuing the deal at 8.4 times and 6.9 times FY22 and FY23E enterprise value/sales, respectively.

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.





Source link

Tags: acquisitionBrandedCuratiodirectICICIPharmaPortfoliostrengthenTorrent
Previous Post

Money management and cleaning ‘among tasks people are most likely to put off’

Next Post

Samsung is copying iOS 16 with latest lock screen customizations

Related Posts

Profit Falls 19%, Misses Estimates

Profit Falls 19%, Misses Estimates

by Varsha Chandnani
May 22, 2025
0

Solar Pharmaceutical Industries Ltd.'s revenue declined within the fourth quarter of fiscal yr 2024-25, thereby lacking the estimates shared by...

ONGC posts ₹8,856 crore profit in Q4 FY25

ONGC posts ₹8,856 crore profit in Q4 FY25

by Euro Times
May 22, 2025
0

State-run ONGC reported a 20 per cent year-on-year (y-o-y) decline in its consolidated web revenue to ₹8,856 crore throughout This...

Tyre stocks are a safe bet amid auto sector uncertainty and falling rubber prices: Anshul Saigal

Tyre stocks are a safe bet amid auto sector uncertainty and falling rubber prices: Anshul Saigal

by Euro Times
May 22, 2025
0

"As you rightly talked about rubber costs have been sort of easing off in latest occasions and because of this,...

Here’s What’s Fueling A Potential 10x Surge In Lucid Stock (NASDAQ:LCID)

Here’s What’s Fueling A Potential 10x Surge In Lucid Stock (NASDAQ:LCID)

by Rick Orford
May 21, 2025
0

This text was written byObserveRick is a Wall Road Journal best-selling writer with over 20 years of expertise buying and...

Why Tariffs Might Be a Golden Opportunity for Resellers

Why Tariffs Might Be a Golden Opportunity for Resellers

by Andrea Vargas
May 22, 2025
0

Tariffs, tariffs, tariffs. That’s what’s been on each enterprise proprietor’s and shopper’s thoughts for the reason that February 2025 announcement...

RVNL Q4 FY25 Results: PAT down 4% at Rs 459 crore; 17% dividend declared

RVNL Q4 FY25 Results: PAT down 4% at Rs 459 crore; 17% dividend declared

by zee business
May 21, 2025
0

RVNL This autumn FY25 Outcomes: Rail Vikas Nigam Ltd (RVNL), a Navratna public sector enterprise, on Wednesday reported a consolidated...

Next Post
Samsung is copying iOS 16 with latest lock screen customizations

Samsung is copying iOS 16 with latest lock screen customizations

Hospitals often reap profits in places where many patients carry medical debt : Shots

Hospitals often reap profits in places where many patients carry medical debt : Shots

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

EU backs tariffs on fertiliser imports from Russia, Belarus | Russia-Ukraine war News

EU backs tariffs on fertiliser imports from Russia, Belarus | Russia-Ukraine war News

May 22, 2025
Profit Falls 19%, Misses Estimates

Profit Falls 19%, Misses Estimates

May 22, 2025
Whale buys back ETH holdings after missing .6M gain

Whale buys back ETH holdings after missing $2.6M gain

May 22, 2025
The Downgrade Is Done. The Investor Response Is Just Beginning

The Downgrade Is Done. The Investor Response Is Just Beginning

May 22, 2025
South Africans React to Ramaphosa’s Meeting With Trump

South Africans React to Ramaphosa’s Meeting With Trump

May 22, 2025
Costamare Bulkers: Interesting Opportunity. Management Has To Perform Long Term (CMDB)

Costamare Bulkers: Interesting Opportunity. Management Has To Perform Long Term (CMDB)

May 22, 2025
Euro Times

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Finance
  • Health
  • Investing
  • Markets
  • Politics
  • Stock Market
  • Technology
  • Uncategorized
  • World

LATEST UPDATES

EU backs tariffs on fertiliser imports from Russia, Belarus | Russia-Ukraine war News

Profit Falls 19%, Misses Estimates

  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In